Cartesian Therapeutics, Inc. — Director's Dealing 2019

Sep 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-09-03

Reporting Person: SPRINGER TIMOTHY A (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-03	Common Stock	J	1237028	—	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1545576	Indirect
Common Stock	86418	Indirect
Common Stock	6056597	Direct

Footnotes

F1: Reflects a liquidating distribution by Leukon Investments, LP to its partners.

F2: Held by Leukon Investments, LP.

F3: Held by TAS Partners LLC.

F4: LKST, Inc. is the general partner of Leukon Investments, LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments, LP and TAS Partners LLC except to the extent of his pecuniary interest therein, if any.